30 April 2025 · Discussion about implementing biosimilar insulin in primary care: key considerations, hints, and tips for systems planning the transition. 10 June 2025.
9 April 2025 · An update supporting implementation of biosimilar and key generic medicines for aflibercept, golimumab, nilotinib and ferric carboxymaltose.
26 March 2025 · Discussion of key current medication safety challenges within healthcare with a focus on the safe use of insulin; inspiring partnership across the system.
4 March 2025 · A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.
25 February 2025 · An update for those involved in medicines governance including managing PGDs and other medicine mechanisms in practice. 13 May 2025.